Jakob Dupont - Jul 29, 2022 Form 3/A - Amendment Insider Report for Apexigen, Inc. (APGN)

Role
Director
Signature
/s/ Francis Sarena, by power of attorney
Stock symbol
APGN
Transactions as of
Jul 29, 2022
Transactions value $
$0
Form type
3/A - Amendment
Date filed
8/24/2023, 07:49 PM
Date Of Original Report
Aug 8, 2022
Previous filing
May 19, 2022
Next filing
Aug 18, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding APGN Stock Option (right to buy) Jul 29, 2022 Common Stock 20.5K $4.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Prior to the date on which the reporting person became subject to Section 16, he was granted an option to purchase 20,489 shares of common stock which vest upon the satisfaction of certain performance metrics. The first threshold was met resulting in the vesting of 5,122 shares. The remaining shares vest upon the achievement of certain additional performance metrics or upon a change in control.

Remarks:

This amendment on Form 3 is filed to report an option that was inadvertently omitted from the Form 3 filed on August 8, 2022.